Welcome to our dedicated page for NO BORDERS news (Ticker: NBDR), a resource for investors and traders seeking the latest updates and insights on NO BORDERS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect NO BORDERS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of NO BORDERS's position in the market.
No Borders, Inc. (OTC:NBDR) announced that its subsidiary, MediDent Supplies, has appointed 360 Health Services as a National Authorized Distributor. 360 Health will leverage MediDent's FDA Registered supply chain to provide critical medical and PPE supplies to clients across the U.S. and Canada. The partnership aims to enhance the distribution of high-demand products like NIOSH N95 masks and syringes. CEO Joe Snyder expressed pride in the collaboration, emphasizing the commitment to meet the urgent needs of government and commercial clients effectively.
No Borders Inc. (OTC: NBDR) announced strong fiscal results for 2020 with record revenues of $8.9M and EBITA of $1.5M, marking significant year-over-year growth since its merger in 2018. The company emphasized its dedication to compliance by filing timely reports and highlighted its MediDent Supplies brand as a key growth driver. Additionally, NBDR is focused on completing PCAOB audits to regain compliance with OTC markets, aiming for an uplisting. The leadership expressed pride in team efforts and the company's capability to scale operations efficiently.
No Borders, Inc. (OTC:NBDR) announced the successful launch of its MediDent Supplies subsidiary's needles and syringes line to support national vaccination efforts against Covid-19. Initial production began in Q3 2020, with shipments delivered to healthcare clients in Q1 2021. The company has ongoing contracts for 2021 and 2022 and aims to provide a stable revenue stream with specialized syringes that can extract six doses per vial. Millions of additional units are en route, bolstering efforts to meet the surging demand in healthcare.
No Borders, Inc. (OTC:NBDR) has announced the launch of its MediDent Supplies needles and syringes line to support U.S. vaccination efforts against COVID-19. Initial production began in Q3 2020, with deliveries made in Q1 2021 to various clients. Ongoing production contracts will enhance revenue through 2021 and 2022. The company has reported high demand, with millions of units shipped and more in transit. MediDent Supplies aims to provide essential medical equipment and PPE, expanding its supply chain capabilities to meet the urgent needs of healthcare facilities.
FAQ
What is the market cap of NO BORDERS (NBDR)?
